Literature DB >> 2122916

The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder.

T R Kosten1, V Wahby, E Giller, J Mason.   

Abstract

Male veterans with posttraumatic stress disorder (PTSD) (n = 11), including 6 with concurrent major depressive disorder (MDD), were compared to veterans with MDD alone (n = 18) and to 28 controls in their response to the dexamethasone suppression test (DST) and thyrotropin-releasing hormone (TRH) stimulation tests. We found higher levels of 4 PM serum cortisol and lower peak thyroid-stimulating hormone (TSH) response to TRH in the MDD patients than in either the PTSD patients or controls, in spite of equivalent levels of depression for MDD and PTSD. DST suppression (cortisol less than 5 mg/dl) occurred in 90% of control, 90% of PTSD, and 78% of MDD subjects, whereas TRH blunting (dTSHmax less than 7 microU/ml) occurred in 28% of control, 27% of PTSD, and 67% of MDD subjects. Rather than blunting, four PTSD patients (36%) and only 10% of the control and MDD subjects had high TSH responses (13-24 microU/ml), which may be linked to high noradrenergic activity, since subclinical hypothyroidism seemed unlikely.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122916     DOI: 10.1016/0006-3223(90)90452-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

1.  Enhanced cortisol suppression following dexamethasone administration in domestic violence survivors.

Authors:  Michael G Griffin; Patricia A Resick; Rachel Yehuda
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

Review 2.  Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis.

Authors:  Matthew C Morris; Bruce E Compas; Judy Garber
Journal:  Clin Psychol Rev       Date:  2012-02-10

3.  The low dose dexamethasone suppression test: effect of time of administration and dose.

Authors:  C Barton; S March; G A Wittert
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

4.  The Two Faces of Janus: Why Thyrotropin as a Cardiovascular Risk Factor May Be an Ambiguous Target.

Authors:  Johannes Wolfgang Dietrich; Rudolf Hoermann; John E M Midgley; Friederike Bergen; Patrick Müller
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-26       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.